0,972  0,002  Respiratory analeptic
0,910  0,003  Analeptic
0,910  0,003  Antihypercholesterolemic
0,904  0,003  UGT1A6 substrate
0,899  0,003  NOS2 expression inhibitor
0,880  0,008  Apoptosis agonist
0,847  0,003  Cholesterol antagonist
0,843  0,004  UDP-glucuronosyltransferase substrate
0,843  0,010  Transcription factor NF kappa B inhibitor
0,834  0,002  UGT1A1 substrate
0,835  0,011  Antiinflammatory
0,830  0,007  TNF expression inhibitor
0,826  0,004  Cardiovascular analeptic
0,827  0,008  Teratogen
0,818  0,002  UGT1A4 substrate
0,813  0,001  UGT2B15 substrate
0,813  0,009  CYP3A4 substrate
0,803  0,003  Hypoxia-inducible factor 1 alpha inhibitor
0,804  0,007  CYP2C9 substrate
0,805  0,009  Antineoplastic (breast cancer)
0,799  0,002  UGT1A3 substrate
0,796  0,003  Anesthetic general
0,797  0,009  Embryotoxic
0,789  0,001  UGT2B4 substrate
0,790  0,003  Anesthetic
0,791  0,007  Carcinogenic
0,773  0,005  Sensitization
0,770  0,005  Prostate cancer treatment
0,757  0,007  Chemopreventive
0,758  0,012  Antineoplastic (lung cancer)
0,762  0,016  Caspase 9 stimulant
0,740  0,005  Nitric oxide antagonist
0,734  0,004  Sulfotransferase substrate
0,733  0,005  Antineoplastic (melanoma)
0,727  0,004  Muscle relaxant
0,727  0,005  NOS3 expression inhibitor
0,695  0,008  CYP2C19 substrate
0,693  0,007  UGT1A9 substrate
0,689  0,005  AR expression inhibitor
0,685  0,005  Cardiotonic
0,666  0,005  Antineoplastic (glioma)
0,656  0,001  UGT2B9 substrate
0,663  0,011  Antineoplastic (ovarian cancer)
0,656  0,007  Hepatic disorders treatment
0,661  0,012  Radioprotector
0,643  0,005  Cardiodepressant
0,638  0,004  Diuretic
0,631  0,002  UGT2B7 substrate
0,635  0,009  Cytotoxic
0,612  0,010  Antipruritic, allergic
0,610  0,013  Bone diseases treatment
0,591  0,004  Skeletal muscle relaxant
0,589  0,004  Phospholipase C inhibitor
0,596  0,012  Proliferative diseases treatment
0,591  0,012  Antineoplastic (pancreatic cancer)
0,602  0,024  Antileukemic
0,587  0,011  Antiosteoporotic
0,575  0,003  Aromatase inhibitor
0,571  0,005  Hair growth stimulant
0,574  0,015  Antineoplastic (cervical cancer)
0,564  0,012  CYP2C19 inhibitor
0,548  0,002  Androgen agonist
0,544  0,005  Prostatic (benign) hyperplasia treatment
0,566  0,027  Antineoplastic (colorectal cancer)
0,561  0,026  Antineoplastic (colon cancer)
0,535  0,019  Chemoprotective
0,525  0,011  Antineoplastic (glioblastoma multiforme)
0,537  0,023  Immunosuppressant
0,521  0,009  Heart failure treatment
0,518  0,010  CYP3A4 inhibitor
0,508  0,004  Androgen antagonist
0,505  0,004  Prostate disorders treatment
0,503  0,004  Sodium/bile acid cotransporter inhibitor
0,503  0,007  Hepatoprotectant
0,501  0,005  UGT2B1 substrate
0,494  0,006  Contraceptive
0,505  0,021  CTGF expression inhibitor
0,507  0,024  CYP2D6 substrate
0,488  0,007  Interferon gamma antagonist
0,484  0,015  ICAM1 expression inhibitor
0,486  0,022  Caspase 3 stimulant
0,473  0,012  Antineoplastic (renal cancer)
0,468  0,013  Antineoplastic (liver cancer)
0,479  0,023  Apoptosis antagonist
0,457  0,005  Lipocortins synthesis antagonist
0,450  0,003  Choleretic
0,482  0,035  Aldehyde oxidase inhibitor
0,448  0,003  Cholesterol synthesis inhibitor
0,435  0,001  Na+ K+ transporting ATPase inhibitor
0,478  0,047  Antibacterial
0,431  0,008  Antiacne
0,435  0,016  Sedative
0,428  0,012  Abortion inducer
0,443  0,030  Cardioprotectant
0,412  0,003  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,433  0,029  Antioxidant
0,405  0,002  UGT2B10 substrate
0,402  0,004  Contraceptive female
0,416  0,019  Antineoplastic (endocrine cancer)
0,409  0,017  Transcription factor STAT3 inhibitor
0,421  0,030  Cytostatic
0,425  0,035  CYP1A2 substrate
0,382  0,008  Antiviral (Influenza A)
0,389  0,027  Antihypoxic
0,369  0,007  Neurotrophic factor enhancer
0,369  0,015  Antiviral (Influenza)
0,393  0,047  Antifungal
0,348  0,002  5-Alpha-reductase inhibitor
0,385  0,042  Lipoprotein disorders treatment
0,344  0,015  Carcinogenic, group 3
0,358  0,031  Transcription factor STAT inhibitor
0,325  0,004  VEGF expression inhibitor
0,324  0,004  Pregnane X receptor agonist
0,358  0,041  Antineoplastic (non-small cell lung cancer)
0,364  0,048  Antineoplastic (brain cancer)
0,353  0,037  Tumour necrosis factor alpha release inhibitor
0,332  0,024  Platelet adhesion inhibitor
0,314  0,020  Antipruritic, non-allergic
0,296  0,001  UGT2B11 substrate
0,355  0,063  Immunostimulant
0,319  0,028  Antihelmintic
0,291  0,001  Anabolic
0,339  0,050  Interleukin 2 agonist
0,322  0,038  Antiparasitic
0,282  0,003  Arachidonic acid antagonist
0,291  0,011  Antifungal enhancer
0,283  0,005  Postmenopausal disorders treatment
0,282  0,007  Farnesoid X receptor antagonist
0,316  0,042  Mutagenic
0,277  0,004  Estradiol 17 beta-dehydrogenase inhibitor
0,311  0,045  Hypolipemic
0,305  0,040  Antineoplastic (sarcoma)
0,267  0,002  RNA-directed RNA polymerase stimulant
0,265  0,003  Anticholelithogenic
0,277  0,025  Melanin inhibitor
0,271  0,023  Amylase inhibitor
0,294  0,051  Angiogenesis stimulant
0,245  0,006  Estrogen agonist
0,260  0,023  Liver fibrosis treatment
0,350  0,122  Cyclophilin D inhibitor
0,350  0,122  Antidiabetic
0,240  0,014  Endometrios treatment
0,287  0,062  DNA damaging
0,296  0,071  Spasmolytic
0,243  0,019  Antihyperlipoproteinemic
0,232  0,010  Antiinfertility, female
0,259  0,039  P-glycoprotein inhibitor
0,246  0,026  Antipruritic
0,246  0,027  Skin whitener
0,237  0,026  Interleukin 6 antagonist
0,222  0,015  Microtubule formation inhibitor
0,267  0,060  Antineoplastic (lymphoma)
0,229  0,025  Antidiarrheal
0,209  0,005  SULT1E1 substrate
0,225  0,022  Antiviral (Hepatitis B)
0,234  0,031  Protein kinase stimulant
0,279  0,079  Antineoplastic (multiple myeloma)
0,281  0,083  Metabolic disease treatment
0,263  0,067  Antiprotozoal (Leishmania)
0,202  0,013  Estrogen antagonist
0,223  0,037  Antineoplastic (squamous cell carcinoma)
0,223  0,039  Protein-tyrosine phosphatase inhibitor
0,203  0,021  Antineoplastic antibiotic
0,213  0,036  NOS3 expression enhancer
0,194  0,030  DNA polymerase I inhibitor
0,200  0,037  ATPase inhibitor
0,191  0,032  Protein-tyrosine phosphatase 1B inhibitor
0,182  0,023  Liver cirrhosis treatment
0,182  0,023  Growth stimulant
0,211  0,053  Growth factor agonist
0,162  0,005  Progesterone antagonist
0,170  0,013  Contraceptive male
0,202  0,046  Antiviral (Herpes)
0,159  0,004  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,191  0,038  Bone formation stimulant
0,205  0,054  Diabetic nephropathy treatment
0,154  0,003  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,219  0,071  Antineoplastic enhancer
0,160  0,014  Estrogen receptor beta antagonist
0,200  0,054  LDLR expression enhancer
0,159  0,014  Transcription factor NF kappa B stimulant
0,234  0,091  Interleukin agonist
0,149  0,008  Glycine receptor antagonist
0,175  0,035  Aldehyde dehydrogenase inhibitor
0,140  0,002  Glucose-6-phosphate dehydrogenase inhibitor
0,140  0,003  Heme oxygenase stimulant
0,221  0,089  Vasodilator
0,186  0,058  Antirickettsial
0,274  0,147  15-Lipoxygenase inhibitor
0,221  0,095  Hypoglycemic
0,156  0,032  SULT1A1 substrate
0,127  0,004  5-Alpha-reductase 1 inhibitor
0,190  0,067  Antiviral (Hepatitis)
0,247  0,124  Antihypertensive
0,126  0,004  Postcoital contraceptive
0,155  0,033  GABA receptor agonist
0,133  0,012  Bile acid receptor antagonist
0,159  0,039  Antihemorrhagic
0,135  0,015  CDC25A inhibitor
0,126  0,009  Estrogen receptor beta agonist
0,124  0,007  Aldosterone antagonist
0,173  0,056  Antineoplastic (carcinoma)
0,147  0,035  Alcohol dehydrogenase substrate
0,121  0,012  Glycine receptor agonist
0,203  0,095  Free radical scavenger
0,112  0,005  SULT2A1 substrate
0,134  0,031  Toll-Like receptor 4 antagonist
0,193  0,092  Antialcoholic
0,105  0,005  5-Alpha-reductase 2 inhibitor
0,172  0,072  Toxic, respiratory center
0,113  0,013  GABA receptor antagonist
0,106  0,008  Estrogen receptor alpha agonist
0,117  0,020  Estrogen receptor alpha antagonist
0,098  0,006  Lipocortins synthesis agonist
0,198  0,110  Myocardial infarction treatment
0,168  0,081  Antineoplastic (bone cancer)
0,149  0,065  Adenylate cyclase stimulant
0,112  0,028  GABA A receptor agonist
0,098  0,016  GABA A receptor antagonist
0,144  0,064  Neurotrophic factor
0,153  0,074  Antimutagenic
0,091  0,013  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,108  0,031  Inducible nitric-oxide synthase inhibitor
0,081  0,005  Farnesoid X receptor agonist
0,185  0,109  VCAM1 expression inhibitor
0,084  0,009  Anesthetic inhalation
0,129  0,056  Monophenol monooxygenase inhibitor
0,198  0,127  DNA synthesis inhibitor
0,148  0,078  Cholinergic
0,074  0,004  Cholesterol absorption inhibitor
0,108  0,041  ABCA1 expression enhancer
0,071  0,008  Glucocorticoid antagonist
0,076  0,013  Opioid kappa receptor agonist
0,170  0,107  Antihypertriglyceridemic
0,066  0,007  Hypogonadism treatment
0,091  0,033  SULT1A2 substrate
0,088  0,033  Cushing's syndrome treatment
0,182  0,130  RNA-directed DNA polymerase inhibitor
0,069  0,018  Acetyl-CoA transferase 2 inhibitor
0,128  0,077  CC chemokine 6 receptor antagonist
0,139  0,088  Acute respiratory distress syndrome (ARDS) treatment
0,135  0,086  Genotoxic
0,066  0,017  Potassium channel Kv1.3 blocker
0,123  0,076  Acetylcholinesterase inhibitor
0,051  0,005  Progesterone agonist
0,231  0,184  Atherosclerosis treatment
0,062  0,018  Mineralocorticoid receptor antagonist
0,085  0,042  Antibiotic
0,127  0,084  Psychosexual dysfunction treatment
0,093  0,053  Antineoplastic alkaloid
0,126  0,087  Lipid peroxidase inhibitor
0,044  0,005  Glucocorticoid agonist
0,083  0,044  Keratolytic
0,071  0,032  Nitric oxide donor
0,042  0,004  Corticosteroid-like
0,210  0,173  GST M1-1 substrate
0,044  0,008  Estrone sulfatase inhibitor
0,045  0,010  HMG CoA reductase inhibitor
0,045  0,011  Tubulin agonist
0,075  0,041  Premenstrual syndrome treatment
0,094  0,061  Antineoplastic, alkylator
0,099  0,066  Hedgehog signaling inhibitor
0,085  0,052  Antiprotozoal activity enhancer
0,061  0,028  Pregnane X receptor antagonist
0,038  0,005  Hedgehog signaling activator
0,100  0,068  Glutathione S-transferase substrate
0,054  0,022  Microtubule stabilization
0,054  0,022  Carbonic anhydrase IV inhibitor
0,207  0,176  Vasodilator, coronary
0,031  0,001  Transcortin receptor antagonist
0,099  0,070  Expectorant
0,086  0,060  Ornithine decarboxylase inhibitor
0,064  0,039  Antimycoplasmal
0,049  0,024  Parathyroid hormone antagonist
0,057  0,033  Protein 50S ribosomal subunit inhibitor
0,087  0,064  Actinic keratosis treatment
0,024  0,004  Vitamin D receptor agonist
0,131  0,111  Male reproductive disfunction treatment
0,168  0,151  Peptidyltransferase inhibitor
0,100  0,088  Cell adhesion inhibitor
0,188  0,177  5 Hydroxytryptamine uptake stimulant
0,091  0,079  Skin irritative effect
0,066  0,055  Andropause treatment
0,021  0,010  Apical sodium codependent bile acid transporter inhibitor
0,023  0,013  Vitamin D receptor antagonist
0,019  0,009  Telomerase stimulant
0,051  0,041  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,099  0,089  Alkylator
0,190  0,182  Angiogenesis inhibitor
0,120  0,113  Eye irritation, high
0,091  0,086  Beta glucuronidase inhibitor
0,174  0,169  Renal disease treatment
0,012  0,009  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,043  0,042  Glucose-6-phosphate isomerase inhibitor
0,039  0,038  GABA B receptor antagonist

